AMERISAFE, Inc.

AMERISAFE, Inc. (AMSF) Market Cap

AMERISAFE, Inc. has a market capitalization of $543.2M.

Price: $29.04

β–Ό -0.31 (-1.06%)

Market Cap: 543.16M

NASDAQ Β· time unavailable

CEO: Gerry Janelle Frost

Sector: Financial Services

Industry: Insurance - Specialty

IPO Date: 2005-11-18

Website: https://www.amerisafe.com

AMERISAFE, Inc. (AMSF) - Company Information

Market Cap: 543.16M|Sector: Financial Services

Company Profile

Operating as an insurance holding company, AMERISAFE, Inc. specializes in providing workers' compensation coverage across the United States. Its policies offer crucial financial protection to injured employees, addressing costs related to temporary or permanent disability, death benefits, and medical and hospital expenses. The firm primarily serves small to medium-sized businesses operating in high-risk industries, including but not limited to construction, trucking, forestry, agriculture, manufacturing, telecommunications, and maritime sectors. AMERISAFE, Inc. was established in 1985 and is headquartered in DeRidder, Louisiana.

Analyst Sentiment

67%
Buy

From 3 Active Polls

1Y Forecast: $32.00

β–² +10.2% Potential Upside

Consensus Target Metrics

Low Bound

$32

Median

$32

High Bound

$32

Average

$32

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$32.00
β–² +10.19% Upside
Low Target
$32.00
10% Risk
Median Target
$32.00
10% Mid
High Target
$32.00
10% Max
Consensus
Buy
3 / 6 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

πŸ“Š Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024
Market Cap ($M)5436326257258328331,000983920
Enterprise Value ($M)478566591663777784956939857
Price to Earnings Ratio (P/E)11.6210.7119.3817.4615.0114.9827.9518.6716.11
Price/Earnings-to-Growth Ratio (PEG)β€”0.72β€”β€”13.771.28β€”β€”4.27
Price to Sales Ratio (P/S)1.626.877.818.8810.1510.2713.7813.2711.69
Price to Book Ratio (P/B)2.172.532.542.883.033.133.843.822.93
Price to Free Cash Flow Ratio (P/FCF)28.13352.84-229.5469.3484.99-87.41-557.6090.90109.23
Enterprise Value to Sales (EV/Sales)β€”6.167.388.129.489.6713.1612.6810.88
Enterprise Value to EBITDA (EV/EBITDA)15.57-55.7257.1951.5944.0144.4283.5755.1247.41
Debt to Equity Ratio-2.13β€”β€”β€”β€”β€”β€”β€”β€”

πŸ“˜ Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

```html

πŸ“˜ AMERISAFE INC (AMSF) β€” Investment Overview

🧩 Business Model Overview

Amerisafe designs, manufactures, and supplies aviation safety restraint systems used in aircraft for passenger and cargo protection. The value chain is characterized by (1) technical qualification and certification work with aviation regulators and aircraft program stakeholders, (2) production and delivery of safety components to aircraft OEMs and their supply chains, and (3) ongoing aftermarket demand for replacement, upgrades, and service support as aircraft fleets accumulate flight cycles and compliance requirements evolve.

A practical way to view the model is that demand is driven by aircraft fleet growth and aircraft utilization (miles/flights), while supply depends on meeting stringent performance standards, documentation, and manufacturing quality systems. Once components are qualified and fielded, the business benefits from repeat ordering and service needs tied to the installed base.

πŸ’° Revenue Streams & Monetisation Model

Revenue is primarily monetized through:

  • Program/OEM supply: sales tied to aircraft production cycles and platform-specific safety requirements.
  • Aftermarket and lifecycle support: replacement and service-related sales influenced by fleet size, aircraft utilization, and inspection/maintenance schedules.

Margin structure is influenced by the mix between OEM and aftermarket volumes, absorption of fixed manufacturing costs across production runs, and the ability to sustain pricing and component-level margins through engineering changes and customer-specific requirements. Given the certification-heavy nature of the product category, the business typically realizes better economics when it is embedded in recurring lifecycle demand rather than relying solely on new-build production.

🧠 Competitive Advantages & Market Positioning

Amerisafe’s durability is rooted in a combination of regulatory/certification moats, switching costs, and installed-base pull from safety components embedded across fleets.

  • Regulatory and qualification barrier (hard-to-replicate): aviation safety restraints require extensive validation, documentation, and compliance work under FAA/EASA-type standards and customer program requirements. This raises the entry cost and lengthens time-to-market for new entrants.
  • Switching costs and engineering lock-in: replacing qualified safety components involves redesign, re-qualification, and operational/maintenance considerations. OEM and airline stakeholders often prefer maintaining certified architectures unless a compelling change is required.
  • Installed-base and lifecycle economics: once systems are fielded, aftermarket replacements and support can follow through aircraft inspections and wear-out patterns, creating a structural demand tail.

Competitive benchmarking: key peers in aviation interior/safety supply include Collins Aerospace (restraint and related safety systems within a broad aerospace portfolio), Safran (aircraft interiors and passenger-related equipment businesses), and ST Engineering (including aviation MRO and components capabilities). While these rivals may compete across adjacent portions of aircraft interior/safety ecosystems, Amerisafe’s positioning is more focused on safety restraint solutions with an emphasis on qualification-led customer inclusion and lifecycle repeat demand.

πŸš€ Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is primarily tied to structural fleet and utilization trends rather than short-cycle discretionary demand:

  • Fleet expansion: global aircraft delivery volumes increase the addressable population for safety systems installed on new platforms.
  • Fleet utilization: higher flight activity drives inspection cadence, replacement needs, and service-related demand across the installed base.
  • Regulatory and standards evolution: ongoing safety and performance expectations can support incremental component demand and engineering programs.
  • Aftermarket penetration: lifecycle support typically offers improved visibility relative to OEM-only exposure, supporting a steadier revenue profile when supply programs are stable.

⚠ Risk Factors to Monitor

  • Aircraft production cycle volatility: OEM sales are exposed to timing and volume changes in aircraft manufacturing schedules.
  • Program execution and qualification risk: engineering changes, qualification timelines, or documentation delays can affect revenue recognition and margins.
  • Customer concentration: reliance on a limited set of OEM and airline supply chains can raise leverage risk during contract renegotiations.
  • Supply chain and manufacturing complexity: component-level quality systems and specialized materials require disciplined sourcing and process control.
  • Technological/process disruption: substitutes or alternative restraint architectures could emerge, though regulatory and certification barriers typically moderate disruption risk.

πŸ“Š Valuation & Market View

The market generally evaluates aviation components and safety equipment businesses on a blend of operating leverage potential, visibility of installed-base aftermarket demand, and durability of gross margin through qualification-led competition. Valuation frameworks often anchor on earnings-based metrics (reflecting industrial-grade operating margins) and on cash flow quality, with additional weight given to backlog/program conversion and lifecycle replacement characteristics.

Key valuation drivers typically include sustainable margin structure, the stability of OEM supply participation, and the long-run trajectory of aftermarket/service mix. Any sustained deterioration in quality/performance outcomes or significant cost inflation from manufacturing inputs can pressure multiples even if demand remains intact.

πŸ” Investment Takeaway

Amerisafe offers an investment profile anchored by aviation safety restraint qualification barriers and lifecycle-driven demand. The moat is structural: regulatory certification and switching costs reduce competitive churn, while the installed-base supports repeat aftermarket needs as fleets grow and accumulate utilization. The principal watch items are program execution, OEM-cycle sensitivity, and maintaining manufacturing quality and cost discipline in a highly standards-driven business.


⚠ AI-generated β€” informational only. Validate using filings before investing.

```

πŸ“° Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for AMSF.

defenseworld.netβ€’2026-07-24

AMERISAFE Q2 Earnings Call Highlights

AMERISAFE (NASDAQ: AMSF) reported higher second-quarter premiums and continued policy growth, while executives said the workers' compensation insurer is navigating a profitable but increasingly competitive market marked by rate pressure and rising medical costs. On the company's second-quarter 2026 earnings call, President and CEO Janelle Frost said the workers' compensation market "remains profitable," but continues to

gurufocus.comβ€’2026-07-22

A Look at AMERISAFE Inc (AMSF) After 8.3% Decline -- GF Value $39.74 vs Price $31.15

On July 22, 2026, AMERISAFE Inc (AMSF) shares fell 8.3% to a current price of $31.15. This decline comes amid a challenging performance period for the stock, wh

seekingalpha.comβ€’2026-07-22

AMERISAFE, Inc. (AMSF) Q2 2026 Earnings Call Transcript

AMERISAFE, Inc. (AMSF) Q2 2026 Earnings Call Transcript

marketbeat.comβ€’2026-07-22

AMERISAFE Q2 Earnings Call Highlights

AMERISAFE NASDAQ: AMSF reported higher second-quarter premiums and continued policy growth, while executives said the workers' compensation insurer is navigating a profitable but increasingly competitive market marked by rate pressure and rising medical costs.

zacks.comβ€’2026-07-22

AMERISAFE Q2 Earnings Miss Estimates Despite Strong Premium Growth

AMERISAFE grows Q2 revenues and premiums, but higher expenses, weaker underwriting margins and lower investment income weighed on earnings.

zacks.comβ€’2026-07-21

Amerisafe (AMSF) Lags Q2 Earnings Estimates

Amerisafe (AMSF) came out with quarterly earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.53 per share a year ago.

businesswire.comβ€’2026-07-21

AMERISAFE Announces 2026 Second Quarter Results

DERIDDER, La.--(BUSINESS WIRE)--AMERISAFE ANNOUNCES 2026 SECOND QUARTER RESULTS.

zacks.comβ€’2026-07-16

Can Higher Premiums Cushion AMERISAFE's Expense Headwinds in Q2?

Can higher net premiums help AMSF offset rising claims costs? Here's what could shape the insurer's Q2 results ahead of its July 21 earnings release.

zacks.comβ€’2026-07-13

Can AMSF Sustain Growth Despite a Tough Workers' Compensation Market?

AMERISAFE, Inc. AMSF continues to distinguish itself in the workers' compensation insurance market through its focus on profitable growth, disciplined underwriting and conservative capital management. As pricing pressure persists across the industry, this strategy has helped the company maintain resilient operating performance and support its long-term investment outlook.

businesswire.comβ€’2026-07-01

AMERISAFE Announces 2026 Second Quarter Earnings Release and Conference Call Schedule

DERIDDER, La.--(BUSINESS WIRE)--AMERISAFE ANNOUNCES 2026 SECOND QUARTER EARNINGS RELEASE AND CONFERENCE CALL SCHEDULE.

zacks.comβ€’2026-06-30

Here's Why Investors Should Retain AMERISAFE Stock for Now

AMSF is seeing steady premium growth, strong policy retention and disciplined underwriting, but investors should also weigh cash flow and valuation concerns.

seekingalpha.comβ€’2026-06-05

Dividend Champion, Contender, And Challenger Highlights: Week Of June 7

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

forbes.comβ€’2026-05-23

7 Special Dividend Payers Shelling Out Up To 14.6%

Using vanilla websites for your dividend research? Be careful.

zacks.comβ€’2026-05-22

Why Is Amerisafe (AMSF) Up 0.7% Since Last Earnings Report?

Amerisafe (AMSF) reported earnings 30 days ago. What's next for the stock?

seekingalpha.comβ€’2026-04-29

Amerisafe: Keeps Growing Into A Soft Market, But The Easy Comparisons Are Behind It

AMERISAFE delivered its eighth consecutive quarter of premium growth, with Q1 2026 net premiums up 9% to $75.1 million. Despite strong underwriting discipline and a 93.2% combined ratio, EPS declined year-over-year due to a normalization of the tax rate and rising loss ratios. Persistent industry rate softness and higher medical costs pressure AMSF's earnings outlook, warranting a Hold rating for patient investors.

πŸ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"AMSF reported Q2’26 Revenue of $91.97M and Net Income of $14.60M (EPS $0.79). On a QoQ basis, revenue rose +14.8% ($91.97M vs $80.09M) while net income increased +79.2% ($14.60M vs $8.15M). However, profitability at the operating level deteriorated sharply: gross profit swung to a loss (gross margin -36.6% vs +42.0% in Q1), and operating income fell to -$10.16M (operating margin -11.0% vs +12.7%). The quarter’s bottom line was supported by strong net β€œother” income ($28.43M), which lifted pre-tax income to $18.27M and net margin to +15.9%. YoY, revenue was up +1.1% (vs $81.10M in Q2’25) but net income rose only +4.6% (vs $13.96M), implying slower earnings growth than revenue. Balance sheet resilience appears intact: total assets were $1.13B with equity of ~$250.0M (slightly up QoQ), and the company carries no total debt. Liquidity improved meaningfully with cash and short-term investments rising to $65.5M (from $34.2M QoQ). Cash flow quality weakened: operating cash flow was only $1.79M in Q2 (after -$2.70M in Q1), but capital intensity was minimal. Shareholder returns are mixed: the stock is down -31.5% over 1Y, with a modest dividend yield ~1.2% (dividends paid ~$7.6M in the quarter) and buybacks continuing (~$4.0M repurchased). Overall, the quarter shows strong net income stability supported by non-operating items, but operating margin volatility remains the key risk."

Revenue Growth

Neutral

QoQ revenue increased +14.8% ($91.97M vs $80.09M). YoY revenue was slightly higher at +1.1% ($91.97M vs $81.10M), suggesting limited underlying top-line acceleration.

Profitability

Neutral

Despite net income improving QoQ (+79.2%), operating performance deteriorated dramatically: gross margin fell to -36.6% (from +42.0% in Q1) and operating margin to -11.0% (from +12.7%). Net margin remained positive at 15.9%, largely due to strong other income.

Cash Flow Quality

Caution

Operating cash flow was low at $1.79M vs -$2.70M QoQ, indicating improvement but still weak conversion of earnings. Free cash flow was ~$1.79M. Dividends were paid (~$7.6M) and buybacks continued (~$4.0M).

Leverage & Balance Sheet

Positive

No debt reported (total debt = 0). Equity was stable-to-up QoQ (about $250.0M from $246.6M), and liquidity improved with cash/short-term investments rising to $65.5M.

Shareholder Returns

Neutral

Total shareholder return appears pressured by price momentum: 1Y change is -31.5% and 6M -16.0%. Dividend yield is modest (~1.2%), partially offsetting capital depreciation. Buybacks were present but likely not enough to counter the stock decline.

Analyst Sentiment & Valuation

Neutral

Consensus price target is $32 versus the current price of $34 (slightly below spot). Analyst valuation support is limited, but the lack of leverage risk can make downside less severe than for highly levered peers.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

AMERISAFE delivered continued premium momentum in Q2 2026, posting a ninth straight quarter of premium growth with net premiums earned up 11.4% to $77.3M and renewal retention >93%. Underwriting held an accident-year loss ratio of 72%, supported by $7.3M of favorable prior-year reserve development and $4.1M of audit premiums (substantially higher than last year). Offsetting that strength, operating net income declined to $8.3M ($0.44) from $10.0M ($0.53), and the expense ratio rose to 31.8% from 31.3% due to a non-recurring bad-debt write-off (~$700k) on an older disputed pre-2023 account. Investment income slipped 2.4% as average investable assets fell with capital returns, though yields remained supportive (+91 bps above roll-off). Management reiterated a mid-single-digit growth trajectory via selective new business and disciplined renewals, while highlighting persistent industry headwinds: rate reductions, real medical inflation (+4% severity/medical inflation in 2025), and intensified competitor aggression, particularly from package carriers.

AI IconGrowth Catalysts

  • Ninth consecutive quarter of premium growth; net premiums earned +11.4% YoY to $77.3M with strong renewal retention >93%
  • Favorable audit premium activity: $4.1M contributed to gross written premiums vs $1.5M prior year
  • Policy count growth continued despite intense competition; gross premiums written +7.9% to $86.0M and voluntary premiums on policies written +5.7% YoY
  • Accident year loss ratio held at 72%; claim frequency up at six months while severity down at six months; favorable reserve development $7.3M from accident years 2023 and prior

Business Development

    AI IconFinancial Highlights

    • Net income $14.6M ($0.78 diluted) vs $14.0M ($0.73) prior year; operating net income $8.3M ($0.44) vs $10.0M ($0.53)
    • Gross written premiums +7.9% to $86.0M; net premiums earned +11.4% to $77.3M
    • Expense ratio 31.8% vs 31.3% YoY; increase driven by one-time items not expected to recur (bad debt write-off ~ $700k on an older disputed pre-2023 account)
    • Effective tax rate 20.1%, unchanged YoY
    • Net investment income $6.5M down 2.4% YoY due to lower average investable assets from dividends/share repurchases; investment yields exceeded roll-off by ~91 bps; tax-equivalent book yield +3.9% (up 6 bps YoY)
    • RORAE 23.5% and book value per share $13.49, up 0.7% YTD
    • Held-to-maturity unrealized loss position net loss $5.6M; equity securities unrealized gain $8.1M vs $1.8M prior year quarter
    • Accident-year loss dynamics: current accident year loss ratio 72%; frequency up vs prior accident year at six months, severity down; favorable prior-year reserve development $7.3M

    AI IconCapital Funding

    • Share repurchase: ~181,000 shares at average $30.58; total $5.6M returned to shareholders
    • Cash/investments at quarter end: approximately $771M in investments, cash, and cash equivalents
    • Statutory surplus $200.8M at quarter end vs $217.8M at year-end 2025

    AI IconStrategy & Ops

    • Underwriting stance: prioritize profitable growth over pure growth; selective new business and renewal retention emphasized
    • Sales/agency initiatives launched several years ago continue to produce results; renewal retention remains >93%
    • Medical inflation management approach: proponents of fee schedules and vendor adherence to fee schedules to contain severity pressure
    • Operating expense increase attributed to non-recurring bad debt write-off from an older account

    AI IconMarket Outlook

    • Remainder of 2026 focus unchanged: profitable growth, operational excellence, strong capital management, long-term shareholder value creation
    • Mid-single-digit growth trajectory expected to be sustained (renewal retention and selectivity emphasized)
    • All 2026 rate filings largely completed; 2027 filings expected to begin in a couple of months; early indications suggest slight decline in the rate of reduction but still reductions

    AI IconRisks & Headwinds

    • Industry-wide softening: rate reductions, increasing medical costs, moderating reserve redundancies, and heightened competition continue to pressure results
    • Competition increasingly aggressive from some regular competitors, especially package carriers (analyst asked if bigger players stepping up; management described more aggression rather than attribution to specific bigger entrants)
    • Medical inflation risk: 2025 industry medical inflation +4% and severity +4% (unadjusted for wages); rates continue to decline despite real medical cost pressure
    • Investable asset base shrinking due to capital returns: net investment income down 2.4% YoY driven by lower average investable assets
    • Unrealized loss position: HTM portfolio classified held-to-maturity with net unrealized loss of $5.6M (economic/interest-rate and credit spread sensitivity)

    Q&A: Analyst Interest

    • Competition and who is gaining: Management said competition remains intense and described β€œa little more aggression” from regular competitors, particularly package carriers. They did not attribute gains to specific larger players; instead emphasized market softening and underwriting selectivity as the differentiator.
    • Audit activity, payroll/wage growth, and renewal cycle timing: Management characterized Q2 audit activity as robust and cited ~4%–4.5% wage change with ~4.7% referenced; employee count remained a low percentage of ~5% overall growth. They connected wage inflation to future audit premiums amid industry rate reductions (~-5% in 2025).
    • Medical inflation and rate filing implications (CA/NV/New Mexico): Management noted cumulative trauma appears unique to California, but also blamed broader industry mismatch: medical inflation rising while rates decline (mid-single-digit reductions; CA ~10%). They referenced Nevada -32% due to structural change and New Mexico -15%, stating 2026 filings mostly done and 2027 early signals imply slightly less reduction pace.

    Sentiment: MIXED

    Note: This summary was synthesized by AI from the AMSF Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

    πŸ“‹ Official Regulatory 10-K / 10-Q SEC Filings

    Direct authenticated documentation links to audited SEC database reports for AMSF.

    SEC EDGAR Live Feed
    Loading financial data and tables...
    πŸ“

    SEC Filings (AMSF)

    Β© 2026 Stock Market Info β€” AMERISAFE, Inc. (AMSF) Financial Profile